However, due to the crucial role of SKP2 in cell cycle progression in normal and tumor cells, the identification of those SKP2 targeting compounds that can be more effective in that specific tumor context and the knowledge of the tumor-specific pathological mechanisms should be considered for translational purposes (refs. 53,65,66). The gene discussed is SKP2; the disease is neoplasm.